1st Faculty of Medicine Charles University 1st Faculty of Medicine Charles University Stopka Lab
tstopka 16.07.2017

Karina Vargová - MS on miR-155/miR-150 network in CLL now in press in BCJ

MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia.

K Vargova, M Pesta, P Obrtlíkova, N Dusilkova, L Minarik, J Vargova, A Berkova, Z Zemanova, K Michalova, M Spacek, M Trneny and T Stopka.

Blood Cancer J. 2017 in press (IF:6.126)



 
tstopka 16.07.2017

Hana Hušková - MS on cancer driver NOW in Oncogene

Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing.

Huskova H, Ardin M, Weninger A, Vargova K, Barrin S, Villar S, Olivier M, Stopka T, Herceg Z, Hollstein M, Zavadil J, Korenjak M.

Oncogene. 2017 Jul 10.



Výsledek obrázku pro Oncogene logo

 
tstopka 30.05.2017

Tomáš Stopka : MDS news (in czech)

Využití detekce somatických mutací pro pacienty s cytopenií nejasného významu a u myelodysplastického syndromu.

Tomáš Stopka, MDS news 2017 str 18, roč. 5, č. 1
 


tstopka 15.05.2017

Jarmila Vargová: MARCKS: new therapeutic target in MCL


Differential Expression, Localization and Activity of MARCKS between Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia. J. Vargova, K. Vargova, N.Dusilkova, V. Kulvait, V. Pospisil, J. Zavadil, M. Trneny, P. Klener, and T. Stopka. Blood Cancer J accepted (IF: 4.502)


ohlasy v tisku:

http://www.ctidoma.cz/zpravodajstvi-zdravi/2016-10-05-cesti-odbornici-zjistili-jak-vylecit-rakovinu-krve-26743

http://sciencemag.cz/cesti-vedci-na-stope-novym-lekum-proti-lymfomum/

 

Výsledek obrázku pro Blood Cancer Journal logo

tstopka 30.09.2016

ASH 2016


Vít Pospíšil et al.

TITLE: Graded PU.1 Levels Regulate Granulocyte Vs. Macrophage Genes Via Multiple Enhancer Elements

Session Name: 201. Granulocytes, Monocytes, and Macrophages: Myeloid Cells and Immunological Imbalances
Session Date: Sunday, December 4, 2016
Session Time: 4:30 PM - 6:00 PM
Presentation Time: 4:30 PM
Room: San Diego Convention Center, Room 33


Kamila Polgárová et al.

TITLE: Clonal Architecture of MDS Somatic Mutations Dynamically Changes during Azacitidine Therapy and Has Very Limited Potential to Predict Patient Outcome

Session Name: 636. Myelodysplastic Syndromes—Basic and Translational Studies: Poster III
Date: Monday, December 5, 2016
Presentation Time: 6:00 PM - 8:00 PM

Location: San Diego Convention Center, Hall GH


Jarmila Vargová et al.

TITLE: Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Is a New Biomarker for Mantle Cell Lymphoma: Expression, Localization, and Phosphorylation Study

Session Name: 622. Lymphoma Biology—Non-Genetic Studies: Poster I
Date: Saturday, December 3, 2016
Presentation Time: 5:30 PM - 7:30 PM

Location: San Diego Convention Center, Hall GH


Zuzana Zemanová et al.

TITLE: Frequency and Clinical Impact of Cytogenetic Clonal Evolution in Myelodysplastic Syndromes (MDS) with Isolated Del(5q)

Session Name: 637. Myelodysplastic Syndromes—Clinical Studies: Poster I
Date: Saturday, December 3, 2016
Presentation Time: 5:30 PM - 7:30 PM
Location: San Diego Convention Center, Hall GH